Even with new entrants edging into the crowded irritable bowel disease (IBD) market and potentially threatening Entyvio’s ...

A new initiative from Blueprint Medicines is adding some color to the experiences of people with systemic mastocytosis (SM).

The end of an era is nearing for Lundbeck. After a 17-year collaboration with Takeda on depression drug Trintellix, the ...

The whole RSV vaccine field took a beating when the CDC’s immunization committee doled out a limited recommendation last ...

Darzalex Faspro is the subcutaneous version of J&J's stalwart multiple myeloma drug Darzalex, which was first approved in ...

Teva and its long-term investors have been through much disappointment over the last decade, but 2024 is bringing optim | ...

The musical sponsored by UCB, “It's All Your Fault, Tyler Price!,” will run for six weeks and features a cast and crew with ...

Sanofi spinoff EuroAPI as it lays the groundwork for longer-term growth with its FOCUS-27 restructuring plan. | After ...

Sanofi subsidiary Genzyme has filed a complaint in U.S. District Court in Delaware claiming that in producing groundbreaking ...

The new results are from an extension of an 18-month study, which set up Leqembi for FDA approval last year and showed it reduced cognitive decline by 27% compared to placebo. Among the patients who ...

For more than a year after Pfizer’s COVID product sales peaked at the end of 2022, the company’s quarterly revenues showed ...

The HPV vaccine, which has been on a juggernaut trajectory this decade thanks to booming sales in China, generated revenue of ...